Call Us: (513) 621-5112

 
 
 
 
 
 
Sterling Research Blog
 
Contrave Approved by the FDA for Weight Loss
Friday, September 12, 2014

These are exciting days in the world of Clinical Research. On September 10th Contrave, a medication we are actively studying at Sterling Research, was approved by the FDA for weight loss. It is always satisfying when a study medication makes it to the market. Now, millions of people may benefit from Contrave. This accomplishment would not have been attained without the help of study volunteers. I commend all of the Medical Heroes that participate in Clinical Trials!

-Dr. Wenker




 
 
Subscribe To Our Blog

Blog Categories

  • Articles
  • News
    • 03/28/2016 - Acne: More Than Just Pimples
    • 08/11/2015 - It's Coming...You Know It Is..
    • 02/10/2015 - Attorney General's Office Dema
    • 10/16/2014 - Regeneron, Sanofi drug slashes
    • 10/10/2014 - Ongoing Ebola Epidemic
    • 09/12/2014 - Contrave Approved by the FDA f
    • 07/11/2014 - Saxenda Recommended for Approv
    • 09/04/2013 - Only Half of Hypertensive Adul

Tag Cloud
 
 
 

CONTACT US
NEWS & ARTICLES
Call For Participation
Patient Recruitment Specialist
Cincinnati, OH

PH: (513) 621-5112
FX:  (513) 621-5101

Cincinnati / Mt. Auburn
2230 Auburn Avenue
Level B
Cincinnati, OH 45219
PH: (513) 381-4100
FX:  (513) 381-4120

Springdale
375 Glensprings Drive
2nd Floor
Cincinnati, OH 45246
PH: (513) 671-8080
FX:  (513) 671-8090
New Drug Prevents Heart Attacks in High-Risk Patients
Thursday, March 23, 2017

A new heart drug cuts cholesterol levels to once unthinkable lows, a treatment that doctors hope may prevent future heart attacks or stroke in high-risk patients, according to results from a highly anticipated study released Friday.

 
 
 



Copyright © 2017. STERLING RESEARCH. All Rights Reserved